Non-coding RNAs regulating mitochondrial function in cardiovascular diseases

X Ao, W Ding, X Li, Q Xu, X Chen, X Zhou… - Journal of Molecular …, 2023 - Springer
Cardiovascular disease (CVD) is the leading cause of disease-related death worldwide and
a significant obstacle to improving patients' health and lives. Mitochondria are core …

[HTML][HTML] Non-coding RNA-mediated modulation of ferroptosis in cardiovascular diseases

Y Liu, W Ding, J Wang, X Ao, J Xue - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Cardiovascular disease (CVD) is a major contributor to increasing morbidity and mortality
worldwide and seriously threatens human health and life. Cardiomyocyte death is …

T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

G Ghilardi, JA Fraietta, JN Gerson, VM Van Deerlin… - Nature Medicine, 2024 - nature.com
We report a T cell lymphoma (TCL) occurring 3 months after anti-CD19 chimeric antigen
receptor (CAR) T cell immunotherapy for non-Hodgkin B cell lymphoma. The TCL was …

[HTML][HTML] Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications

X Zhou, X Ao, Z Jia, Y Li, S Kuang, C Du… - Frontiers in …, 2022 - frontiersin.org
Cancer is one of the most frequently diagnosed malignant diseases worldwide, posing a
serious, long-term threat to patients' health and life. Systemic chemotherapy remains the first …

[HTML][HTML] Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications

Y Liu, W Ding, J Wang, X Ao, J Xue - Frontiers in oncology, 2023 - frontiersin.org
Lung cancer (LC) is a heterogeneous disease with high malignant degree, rapid growth,
and early metastasis. The clinical outcomes of LC patients are generally poor due to the …

[HTML][HTML] The interaction of polyphenols and the gut microbiota in neurodegenerative diseases

Y Zhang, W Yu, L Zhang, M Wang, W Chang - Nutrients, 2022 - mdpi.com
Polyphenols are secondary metabolites of plants and play a potential role in the prevention
and treatment of neurodegenerative diseases (NND) such as Alzheimer's disease (AD) and …

FOXO3a in cancer drug resistance

Y Liu, Y Wang, X Li, Y Jia, J Wang, X Ao - Cancer Letters, 2022 - Elsevier
Cancer is one of the major causes of death and a significant obstacle to increasing life
expectancy worldwide. Chemotherapy remains the first-line adjuvant therapeutic option for …

The FOXO family of transcription factors: key molecular players in gastric cancer

Y Liu, X Ao, Y Jia, X Li, Y Wang, J Wang - Journal of Molecular Medicine, 2022 - Springer
Gastric cancer (GC) is the fifth most frequently diagnosed cancer worldwide and the third
leading cause of cancer-related death with an oncological origin. Despite its decline in …

Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression

Y Liu, Y Li, C Du, S Kuang, X Zhou, J Zhang… - Journal of Molecular …, 2022 - Springer
Cancer is the second-leading disease-related cause of global mortality after cardiovascular
disease. Despite significant advances in cancer therapeutic strategies, cancer remains one …

[HTML][HTML] Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications

M Wang, F Yu, P Li - Frontiers in Immunology, 2023 - frontiersin.org
The increasing knowledge in the field of oncoimmunology has led to extensive research into
tumor immune landscape and a plethora of clinical immunotherapy trials in cancer patients …